VN
Venugopalan Nair
About Venugopalan Nair
Data last updated:
Venugopalan Nair was a Director at Edkal Technologies Private Limited (2013–2020), Whole-Time Director at Sami-Sabinsa Group Limited (2011–2021) and Director at Organica Aromatics Private Limited (2018–2020), and held 3 more directorships. The companies operate in Information Technology, Healthcare and Chemicals and Materials.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 May 2013 | 2005 | ₹12.3 Lakh (FY 2025) | Active | |
| Whole-Time Director | 11 Jun 2011 | 1991 | ₹1,137 Cr (FY 2025) | Active | |
| Director | 24 May 2018 | 1999 | ₹93.85 Cr (FY 2025) | Active | |
| Director | 23 Aug 2006 | 1992 | ₹29.16 Cr (FY 2022) | Under Cirp | |
| Director | 13 Mar 2007 | 2007 | ₹8.98 Cr (FY 2024) | Active | |
| Director | 15 Sep 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venugopalan Nair
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venugopalan Nair
Venugopalan Nair was first appointed on 23 Aug 2006 as Director at Stellence Pharmscience Private Limited. The most recent appointment on record is 24 May 2018 at Organica Aromatics Private Limited.
Venugopalan Nair held 6 earlier board appointments: Edkal Technologies Private Limited (Director, 31 May 2013 to 01 Aug 2020); Sami-Sabinsa Group Limited (Whole-Time Director, 11 Jun 2011 to 01 Aug 2021); Organica Aromatics Private Limited (Director, 24 May 2018 to 01 Aug 2020); Stellence Pharmscience Private Limited (Director, 23 Aug 2006 to 23 Nov 2010); Xenocor Pharmalab Private Limited (Director, 13 Mar 2007 to 10 May 2010); and 1 more.